Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2080222217Phase 3Completed
Phase 3 trial of volasertib in cancer. Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2080222217.